Arthroscopic surgery is a common orthopaedic procedure in middle-aged patients with knee symptoms.^[@bibr9-2325967119893920],[@bibr50-2325967119893920]^ However, even in the absence of knee symptoms, in the general population and within this age group, incidental findings of meniscal lesions on magnetic resonance imaging (MRI) are very common.^[@bibr12-2325967119893920]^ It was suggested that a meniscal injury in middle-aged patients should be considered an indicator of incipient knee osteoarthritis (OA).^[@bibr13-2325967119893920]^ Consequently, the patient's symptoms might not be caused by a degenerative meniscus alone but might arise from multiple factors attributable to early OA.^[@bibr3-2325967119893920]^ Previously, several randomized controlled trials (RCTs) have reported that arthroscopic meniscal surgery provided little or no additional benefit over nonsurgical treatment^[@bibr18-2325967119893920],[@bibr19-2325967119893920],[@bibr22-2325967119893920],[@bibr26-2325967119893920],[@bibr27-2325967119893920],[@bibr53-2325967119893920],[@bibr55-2325967119893920]^ or sham surgery.^[@bibr35-2325967119893920],[@bibr41-2325967119893920],[@bibr47-2325967119893920],[@bibr48-2325967119893920]^ Therefore, the issue of how to treat degenerative meniscal injuries has been recently and extensively debated.^[@bibr7-2325967119893920],[@bibr8-2325967119893920],[@bibr31-2325967119893920],[@bibr38-2325967119893920]^ Systematic reviews have concluded that arthroscopic surgery showed a small benefit of pain relief that lasted for up to 6 months but not 2 years after surgery in middle-aged or older patients with knee pain and degenerative knee disease.^[@bibr5-2325967119893920],[@bibr52-2325967119893920],[@bibr54-2325967119893920]^ Nevertheless, the role of arthroscopic surgery in the treatment of degenerative meniscal tears remains controversial.^[@bibr2-2325967119893920],[@bibr30-2325967119893920],[@bibr33-2325967119893920]^ A recent review concluded that these patients could benefit from arthroscopic meniscectomy but that nonsurgical treatment should be considered first.^[@bibr29-2325967119893920]^ Mechanical symptoms were previously considered an indication for surgery; however, recent data have contradicted this tenet.^[@bibr14-2325967119893920],[@bibr46-2325967119893920]^

The follow-up times of most RCTs on this topic have been limited to a maximum of 2 years,^[@bibr26-2325967119893920],[@bibr27-2325967119893920],[@bibr35-2325967119893920],[@bibr47-2325967119893920],[@bibr53-2325967119893920],[@bibr55-2325967119893920]^ except in 2 studies that reported a 5-year follow-up.^[@bibr19-2325967119893920],[@bibr24-2325967119893920]^ Moreover, most RCTs have evaluated only patient-reported outcome measures (PROMs), and only 2 previous RCTs have reported radiographic findings.^[@bibr19-2325967119893920],[@bibr55-2325967119893920]^ Because removing functional meniscal tissue could increase the risk of knee OA,^[@bibr13-2325967119893920]^ additional data are needed regarding the long-term effects, including radiographic changes, of arthroscopic meniscectomy compared with nonoperative treatment.

The present study was the only RCT with comprehensive recruitment from a catchment area, which provided adequate representation of the population^[@bibr33-2325967119893920]^ and demonstrated a statistically and clinically significant positive effect of knee arthroscopic surgery with an exercise program after 1 year compared with an exercise program alone.^[@bibr15-2325967119893920]^ The objectives of the present study were to (1) evaluate whether knee arthroscopic surgery combined with an exercise program provided an additional 5-year benefit compared with an exercise program alone in middle-aged patients with meniscal symptoms, (2) determine whether baseline mechanical symptoms affected the outcome, and (3) compare radiographic changes between treatment groups. We hypothesized that there would be no differences between treatment groups.

Methods {#section1-2325967119893920}
=======

Study Design and Participants {#section2-2325967119893920}
-----------------------------

Participants were recruited from the orthopaedic department at Linköping University Hospital between 2010 and 2012. For this study, eligibility was determined by 1 orthopaedic surgeon (H.G.), who evaluated all patients referred with a suspected meniscal injury. Inclusion criteria were the following: age 45 to 64 years, symptoms for longer than 3 months, standing radiograph with an Ahlbäck grade of 0 (\<50% reduction of the joint space, without consideration of possible osteophytes),^[@bibr1-2325967119893920]^ and prior treatment with physical therapy. Inclusion was based on meniscal symptoms from a medical history and clinical examinations, and MRI was not performed. We believe that MRI is not indicated in the management of this patient population and that treatment should focus on improving symptoms and function. All consecutive patients who fulfilled the inclusion criteria and did not meet any exclusion criteria were invited to participate in the study ([Figure 1](#fig1-2325967119893920){ref-type="fig"}). Details about recruitment were published previously.^[@bibr15-2325967119893920]^

![Patient enrollment and randomization. Exclusion criteria were locked knee or joint locking for more than 2 seconds more often than once a week, rheumatic or neurological disease, fibromyalgia, replacement of hip or knee joints, or a contraindication for surgery (body mass index \>35 kg/m^2^ or a serious medical illness). Groups analyzed in the as-treated analysis: surgery group = a + c (total of 85 patients) and nonsurgery group = b + d (total of 61 patients).](10.1177_2325967119893920-fig1){#fig1-2325967119893920}

The patients were randomly allocated to 1 of 2 parallel intervention groups. One group (nonsurgery) received a physical therapy session within 2 weeks, with a functional assessment and instructions for an exercise program. The other group (surgery) received the same physical therapy treatment within 2 weeks plus knee arthroscopic surgery within 4 weeks of inclusion. Any significant meniscal injuries were resected during the arthroscopic procedure. Group allocations were placed in sequentially numbered, opaque, sealed envelopes in 15 blocks with a block size of 10. After enrollment, the patient and a nurse opened the envelope. The orthopaedic surgeon who enrolled and assessed patients was blinded to the allocation sequence.

The 5-year follow-up data were analyzed with an as-treated approach. Patients who underwent arthroscopic surgery on the index knee between allocation and the 1-year follow-up were included in the surgery group. Patients who did not undergo arthroscopic surgery on the index knee between allocation and the 5-year follow-up were included in the nonsurgery group. Patients were excluded if they underwent arthroscopic surgery on the index knee after the 1-year follow-up ([Figure 1](#fig1-2325967119893920){ref-type="fig"}).

Interventions {#section3-2325967119893920}
-------------

The exercise program aimed to increase muscle function and postural control. This program lasted for 3 months. The physical therapy sessions were held at an independent physical therapy clinic. Surgery was performed by 1 of 2 experienced arthroscopic surgeons at an independent day surgery clinic. During surgery, patients received general or local anesthetics. Based on their own experience, the surgeons judged whether meniscal resection was indicated. All patients were allowed to perform full weightbearing activities immediately after surgery. Patients were advised to resume the exercise program after surgery. Detailed information about the interventions was previously published.^[@bibr15-2325967119893920]^

Patient-Reported Outcome Measures {#section4-2325967119893920}
---------------------------------

Before randomization (baseline), the orthopaedic surgeon assessed the symptom history regarding the presence of mechanical symptoms, defined as daily joint catching and/or joint locking for more than 2 seconds over the past month. Then, the patient was isolated to complete the PROM forms, including the Knee injury and Osteoarthritis Outcome Score (KOOS), the EuroQol 5 dimensions (EQ-5D), and the Physical Activity Scale (PAS). Patients completed the same questionnaires at 3 months, 1 year, 3 years, and 5 years after baseline. There were no planned follow-up visits for the patients at the orthopaedic clinic. Patients completed all follow-up questionnaires at home and returned the forms in an envelope with prepaid postage. The primary outcome was the change in the KOOS-Pain (KOOS~PAIN~) subscore between baseline and the 5-year follow-up. In addition, the change in the KOOS~PAIN~ subscore at 5 years was divided into 3 categories compared with baseline: improved (\>10-point higher score), stable (within 10 points), and deteriorated (\>10-point lower score). These categories were analyzed to evaluate clinically relevant changes. Detailed information about the outcomes was previously published.^[@bibr15-2325967119893920]^

Radiographic Assessment {#section5-2325967119893920}
-----------------------

Weightbearing radiographs were obtained at baseline and the 5-year follow-up. One radiologist (J.Y.), who was blinded to the allocation and treatment, assessed all radiographs according to the Kellgren-Lawrence grade.^[@bibr25-2325967119893920]^ The grades were as follows: grade 0, no radiographic features of OA present; grade 1, possible osteophytes only; grade 2, definite osteophytes and possible joint space narrowing; grade 3, moderate osteophytes and/or definite narrowing; and grade 4, large osteophytes, severe joint space narrowing, and/or bony sclerosis. Radiographic OA was defined as grade ≥2.^[@bibr44-2325967119893920]^ Deteriorations in radiographic findings were also evaluated according to the Kellgren-Lawrence grade.

Adverse Events {#section6-2325967119893920}
--------------

Adverse events were identified with the 5-year questionnaire and a review of the electronic medical records after 3 years. There were no reports of deep venous thrombosis, infections, or other complications during the first 3 years postoperatively. There were 2 revision arthroscopic procedures of the medial meniscus in the surgery group; 1 revision resection was performed at 10 months, and the other was performed at 21 months after inclusion.

Response and Dropout Analysis {#section7-2325967119893920}
-----------------------------

We analyzed the patient characteristics and baseline data of the group of patients who responded to the questionnaire (n = 102) compared with those who did not respond (n = 44) at 5 years. A dropout analysis was performed by contacting patients who did not answer the questionnaire at 5 years but did not decline further study participation (n = 28). These patients were asked to participate in a short telephone interview. A physical therapist performed the interview. This interview included questions from the 5-year questionnaire, questions from the PAS, and 3 EQ-5D questions regarding pain (rated on a 3-point scale; eg, no pain, moderate pain, severe pain), knee function (rated on a 10-point scale), and the ability/inability to perform daily activities (eg, limitations/no limitations in daily activities).

Statistical Analysis {#section8-2325967119893920}
--------------------

We used an as-treated approach in the analyses. Analyses were performed with SPSS Statistics for Windows (Version 23.0; IBM), and all analyses were 2-sided, with the significance level set at *P* \< .05. Independent-samples *t* tests were used to analyze cross-sectional between-group differences in PROM scores. Changes in PROM scores at both the 1- and 5-year follow-ups were analyzed with independent-samples *t* tests and analyses of covariance (ANCOVAs); the respective PROM score at baseline was used as a covariate to generate adjusted *P* values. In addition, the changes in PROM scores at the 5-year follow-up were analyzed with 2-way ANCOVAs, with the treatment group and mechanical symptoms as factors and the baseline PROM score as the covariate. Group differences in categorical data were analyzed with the Pearson chi-square test or Fisher exact test.

A minimal change of 8 to 10 points was considered clinically important for the KOOS~PAIN~. Thus, a 10-point change was used as the cutoff to indicate recovery.^[@bibr42-2325967119893920]^ To detect a between-group difference of 10 points (SD, 19) on the KOOS~PAIN~ (α = 0.05; β = 0.8), we included 75 participants in each group; this accounted for a crossover and dropout rate of 33%.

Results {#section9-2325967119893920}
=======

Study Participants {#section10-2325967119893920}
------------------

Patients were randomly assigned to either the surgery (n = 75) or nonsurgery (n = 75) group. Moreover, 19 patients (25%) crossed over from the nonsurgery group to undergo surgery. There were 8 patients (11%) allocated to the surgery group who did not go through with the operative procedure. Of the 75 patients who initially were randomized to surgery, 66 underwent surgery (56 underwent partial meniscal resection, 2 underwent removal of degenerated joint cartilage fragments, 1 underwent resection of loose bodies, 1 underwent synovectomy, 1 underwent partial resection of anterior cruciate ligament remnants, and 8 were judged as not needing surgical treatment). Of the 75 patients who initially were randomized to nonsurgical treatment, 19 crossed over and underwent surgery (12 underwent partial meniscal resection, 1 underwent resection of loose bodies, 1 underwent microfracture, 1 underwent partial resection of anterior cruciate ligament remnants, 1 was judged not to need surgical treatment, and there was missing information for 3 patients). A total of 4 patients were excluded from the 5-year follow-up because they underwent arthroscopic surgery in the index knee after the 1-year follow-up. Consequently, 146 patients were available for the as-treated analysis ([Figure 1](#fig1-2325967119893920){ref-type="fig"}). There was 1 patient in the surgery group who underwent arthroscopic surgery in March 2011 and died in 2014. The 1-year questionnaire was completed by 130 patients (89%), and the 3-year questionnaire was completed by 119 patients (82%). The results from the 1-^[@bibr15-2325967119893920]^ and 3-year^[@bibr14-2325967119893920]^ follow-ups were published previously. The 5-year questionnaire was completed by 102 patients (70%; 66 patients in the surgery group and 36 patients in the nonsurgery group). Weightbearing radiographs were obtained at the 5-year follow-up for 82 patients (56%; 55 patients in the surgery group and 27 patients in the nonsurgery group).

Patient Characteristics and Baseline Data {#section11-2325967119893920}
-----------------------------------------

Patient characteristics, including OA severity, and baseline data are presented in [Tables 1](#table1-2325967119893920){ref-type="table"} and [2](#table2-2325967119893920){ref-type="table"}. The groups were not significantly different in patient characteristics at baseline ([Table 1](#table1-2325967119893920){ref-type="table"}). However, at baseline, the PROMs showed that the surgery group scored lower than the nonsurgery group on the KOOS~PAIN~ (mean difference, --6.8 \[95% CI, --12.5 to 1.1\]; *P* = .020), KOOS--Activities of Daily Living (KOOS~ADL~) (mean difference, --6.9 \[95% CI, --13.1 to --0.7\]; *P* = .029), KOOS--Sports (KOOS~SPORTS~) (mean difference, --10.5 \[95% CI, --17.8 to --3.2\]; *P* = .008), and KOOS--Quality of Life (KOOS~QoL~) (mean difference, --5.7 \[95% CI, --11.0 to --0.4\]; *P* = .036) ([Table 2](#table2-2325967119893920){ref-type="table"}).

###### 

Patient Characteristics at Baseline*^a^*

![](10.1177_2325967119893920-table1)

                                                       Surgery (n = 85)   Nonsurgery (n = 61)   *P*
  ---------------------------------------------------- ------------------ --------------------- -----------
  Age, mean ± SD, y                                    55 ± 5             54 ± 6                .443*^b^*
  Sex, male/female, n                                  43/42              39/22                 .109*^c^*
  Duration of knee pain, median (IQR), mo              7 (8)              7 (8)                 .839*^d^*
  OA severity (Kellgren-Lawrence grade)                                                         .369*^e^*
    0                                                  30 (38)            15 (25)               
    1                                                  18 (23)            19 (32)               
    2                                                  31 (39)            25 (42)               
    3                                                  1 (1)              1 (2)                 
  Sudden onset of pain                                 47 (56)            32 (55)               .927*^c^*
  Mechanical symptoms                                  58 (69)            32 (54)               .071*^c^*
  Age \<55 y                                           42 (49)            32 (53)               .716*^c^*
  Moderate to high physical activity level (PAS 4-6)   27 (33)            19 (33)               .960*^c^*

*^a^*Values are shown as n (%) unless otherwise indicated. IQR, interquartile range; OA, osteoarthritis; PAS, Physical Activity Scale.

*^b^*Independent-samples *t* test.

*^c^*Pearson chi-square test.

*^d^*Mann-Whitney *U* test.

*^e^*Fisher exact test.

###### 

Patient-Reported Outcome Measure Scores*^a^*

![](10.1177_2325967119893920-table2)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                   Baseline         1 y              3 y        5 y                                                                                                                 
  ---------------- ---------------- ---------------- ---------- ---------------- ---------------- ------ ---------------- ---------------- ------ ---------------- ---------------- ----------
  KOOS~PAIN~                                                                                                                                                                        

   n               84               60                          78               48                      70               44                      65               35               

   Mean (95% CI)   53.5\            60.2\            **.020**   84.3\            79.1\            .085   82.4\            80.1\            .557   79.3\            86.0\            .111
                   (50.0 to 56.9)   (55.4 to 65.1)              (80.8 to 87.8)   (74.1 to 84.1)          (77.8 to 87.0)   (73.5 to 86.7)          (74.2 to 84.4)   (79.7 to 92.2)   

  KOOS~SYMPTOMS~                                                                                                                                                                    

   n               83               60                          78               48                      71               44                      66               36               

   Mean (95% CI)   58.5\            62.7\            .176       82.1\            78.9\            .274   82.5\            78.5\            .269   77.1\            85.6\            **.034**
                   (54.9 to 62.0)   (57.6 to 67.9)              (78.7 to 85.5)   (73.7 to 84.0)          (78.2 to 86.8)   (72.5 to 84.4)          (72.1 to 82.1)   (80.0 to 91.3)   

  KOOS~ADL~                                                                                                                                                                         

   n               83               59                          78               48                      71               42                      64               36               

   Mean (95% CI)   63.2\            70.2\            **.029**   86.9\            82.9\            .188   86.5\            81.9\            .203   83.9\            87.9\            .283
                   (59.3 to 67.2)   (65.3 to 75.1)              (83.3 to 90.6)   (77.9 to 87.9)          (82.3 to 92.2)   (75.5 to 88.2)          (79.3 to 88.5)   (82.3 to 93.4)   

  KOOS~SPORTS~                                                                                                                                                                      

   n               83               59                          78               48                      71               44                      65               35               

   Mean (95% CI)   26.4\            36.9\            **.008**   57.2\            58.9\            .744   61.5\            61.9\            .948   57.7\            65.9\            .186
                   (22.4 to 30.5)   (30.3 to 43.6)              (51.2 to 63.3)   (51.0 to 66.7)          (54.3 to 68.6)   (52.7 to 71.1)          (50.5 to 64.9)   (55.6 to 76.2)   

  KOOS~QoL~                                                                                                                                                                         

   n               84               59                          78               48                      71               44                      65               36               

   Mean (95% CI)   31.8\            37.5\            **.036**   64.3\            60.4\            .348   69.6\            66.8\            .547   65.3\            68.1\            .585
                   (28.6 to 35.0)   (33.0 to 42.0)              (59.2 to 69.4)   (53.7 to 67.1)          (63.8 to 75.5)   (59.2 to 74.4)          (59.4 to 71.2)   (59.4 to 76.7)   

  EQ-5D                                                                                                                                                                             

   n               83               59                          78               48                      68               41                      65               36               

   Mean (95% CI)   0.61\            0.65\            .264       0.83\            0.83\            .873   0.86\            0.80\            .134   0.81\            0.86\            .181
                   (0.55 to 0.66)   (0.59 to 0.71)              (0.78 to 0.87)   (0.79 to 0.87)          (0.82 to 0.90)   (0.73 to 0.87)          (0.76 to 0.86)   (0.81 to 0.91)   

  EQ-VAS                                                                                                                                                                            

   n               82               58                          77               47                      68               42                      64               34               

   Mean (95% CI)   60.9\            65.9\            .157       77.2\            76.1\            .716   78.7\            76.9\            .623   79.0\            83.5\            .160
                   (56.5 to 65.2)   (60.2 to 71.5)              (73.2 to 81.3)   (71.7 to 80.5)          (74.2 to 83.2)   (71.6 to 82.2)          (75.1 to 83.0)   (79.0 to 88.0)   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^*Data are based on the total cohort of patients at each evaluation time point. Bolded values indicate statistical significance (*P* \< .05). ADL, activities of daily living; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.

Patient-Reported Outcome Measures {#section12-2325967119893920}
---------------------------------

The groups showed no difference in the change in the KOOS~PAIN~ subscore from baseline to 5 years in either the unadjusted or adjusted analysis (*P* = .500 and *P* = .403, respectively) ([Table 3](#table3-2325967119893920){ref-type="table"} and [Figure 2](#fig2-2325967119893920){ref-type="fig"}). The surgery group improved more than the nonsurgery group on the KOOS~PAIN~ from baseline to 1 year according to the unadjusted analysis (difference in mean change, 11.8 \[95% CI, 3.6 to 19.9\]; *P* = .005), but this difference was no longer significant in the adjusted model when the baseline KOOS~PAIN~ subscore was considered a covariate (adjusted *P* = .194). There was a difference between groups in the change in the KOOS~PAIN~ subscore from 3 to 5 years in favor of the nonsurgery group (difference in mean change, 5.8 \[95% CI, --0.2 to 11.7\]; *P* = .058; adjusted *P* = .038) ([Table 3](#table3-2325967119893920){ref-type="table"}). Greater than a 10-point improvement on the KOOS~PAIN~ at 5 years was observed in 75% (n = 49) of patients in the surgery group compared with 74% (n = 26) of patients in the nonsurgery group. Only 1 patient in each group (2% in the surgery group and 3% in the nonsurgery group) reported a deterioration of more than 10 points on the KOOS~PAIN~ at 5 years (*P* \> .999) ([Figure 3](#fig3-2325967119893920){ref-type="fig"}).

###### 

Change in Patient-Reported Outcome Measure Scores*^a^*

![](10.1177_2325967119893920-table3)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                   Baseline to 1 y*^b^*   Baseline to 5 y   3 to 5 y                                                                                                                                       
  ---------------- ---------------------- ----------------- ------------------ ------ ---------------- ---------------- ------------------ ------ ------------------ ------------------ ------------------ ----------
  KOOS~PAIN~                                                                                                                                                                                               

   n               62                     33                                          65               35                                         61                 31                                    

   Mean (95% CI)   31.1\                  19.4\             11.8\              .194   25.8\            22.6\            3.2\               .403   --1.2\             4.6\               5.8\               **.038**
                   (26.4 to 35.8)         (12.3 to 26.5)    (3.6 to 19.9)             (20.2 to 31.3)   (15.1 to 30.2)   (--6.1 to 12.4)           (--4.5 to 2.2)     (--0.8 to 10.0)    (--0.2 to 11.7)    

   *P* value                                                **.005**                                                    .500                                                            .058               

  KOOS~SYMPTOMS~                                                                                                                                                                                           

   n               61                     33                                          65               36                                         63                 32                                    

   Mean (95% CI)   25.0\                  18.3\             6.7\               .321   17.9\            19.9\            2.0\               .124   --4.0\             3.9\               7.9\               **.008**
                   (21.2 to 28.8)         (11.8 to 24.7)    (--0.2 to 13.6)           (12.9 to 22.9)   (13.2 to 26.7)   (--6.2 to 10.3)           (--7.7 to --0.3)   (--0.8 to 8.6)     (1.8 to 14.1)      

   *P* value                                                .057                                                        .625                                                            **.011**           

  KOOS~ADL~                                                                                                                                                                                                

   n               62                     32                                          64               35                                         61                 31                                    

   Mean (95% CI)   23.7\                  12.7\             11.0\              .116   20.4\            14.0\            6.4\               .975   --1.0\             3.9\               4.9\               .141
                   (19.2 to 28.2)         (7.0 to 18.5)     (3.5 to 18.4)             (15.4 to 25.4)   (7.0 to 20.9)    (--2.0 to 14.9)           (--4.6 to 2.6)     (--1.5 to 9.4)     (--1.4 to 11.2)    

   *P* value                                                **.004**                                                    .134                                                            .124               

  KOOS~SPORTS~                                                                                                                                                                                             

   n               62                     33                                          65               34                                         62                 31                                    

   Mean (95% CI)   32.2\                  23.8\             8.4\               .767   30.7\            24.3\            6.4\               .934   --2.4\             0.8\               3.1\               .372
                   (25.5 to 38.8)         (14.0 to 33.6)    (--3.0 to 19.8)           (23.9 to 37.6)   (13.6 to 35.0)   (--5.7 to 18.5)           (--7.4 to 2.6)     (--8.6 to 10.1)    (--6.4 to 12.7)    

   *P* value                                                .148                                                        .296                                                            .514               

  KOOS~QoL~                                                                                                                                                                                                

   n               62                     33                                          65               35                                         62                 32                                    

   Mean (95% CI)   33.1\                  24.3\             8.8\               .416   33.7\            27.1\            6.6\               .816   --3.2\             0.2\               3.4\               .433
                   (26.8 to 39.4)         (16.2 to 32.4)    (--1.6 to 19.2)           (27.3 to 40.1)   (18.6 to 35.6)   (--4.0 to 17.2)           (--8.0 to 1.6)     (--6.7 to 7.1)     (--4.8 to 11.6)    

   *P* value                                                .095                                                        .217                                                            .409               

  EQ-5D                                                                                                                                                                                                    

   n               61                     32                                          64               35                                         59                 30                                    

   Mean (95% CI)   0.24\                  0.15\             0.10\              .782   0.22\            0.17\            0.04\              .313   --0.03\            0.05\              0.08\              .117
                   (0.18 to 0.31)         (0.08 to 0.22)    (--0.01 to 0.20)          (0.14 to 0.29)   (0.09 to 0.25)   (--0.07 to 0.16)          (--0.08 to 0.01)   (--0.03 to 0.13)   (--0.00 to 0.17)   

   *P* value                                                .076                                                        .433                                                            .062               

  EQ-VAS                                                                                                                                                                                                   

   n               60                     31                                          63               33                                         59                 30                                    

   Mean (95% CI)   15.8\                  10.2\             5.6\               .870   18.4\            16.7\            1.7\               .479   --0.1\             4.5\               4.6\               .105
                   (10.4 to 21.2)         (4.3 to 16.2)     (--3.0 to 14.2)           (13.8 to 23.1)   (10.2 to 23.2)   (--6.1 to 9.6)            (--4.3 to 4.0)     (--0.0 to 9.0)     (--2.0 to 11.2)    

   *P* value                                                .199                                                        .663                                                            .169               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*^a^*Bolded values indicate statistical significance (*P* \< .05). ADL, activities of daily living; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.

*^b^*Data from the cohort of patients who answered the questionnaire at baseline, the 1-year follow-up, and the 5-year follow-up.

*^c^*Adjusted for overall mean scores at baseline.

*^d^*Adjusted for overall mean scores at the 3-year follow-up.

![Mean Knee injury and Osteoarthritis Outcome Score (KOOS)--Pain subscore at baseline, 1 year, 3 years, and 5 years according to treatment group.](10.1177_2325967119893920-fig2){#fig2-2325967119893920}

![Percentage of patients in each treatment group who showed the indicated change in the Knee injury and Osteoarthritis Outcome Score (KOOS)--Pain subscore from baseline to 5 years. Dotted horizontal lines indicate a 10-point change from baseline.](10.1177_2325967119893920-fig3){#fig3-2325967119893920}

There were no between-group differences from baseline to 5 years in the change in KOOS-symptoms (KOOS~SYMPTOMS~), KOOS~SPORTS~, KOOS~ADL~, or KOOS~QoL~ subscores (*P* \> .05). The surgery group showed more improvement than the nonsurgery group on the KOOS~ADL~ from baseline to 1 year according to the unadjusted analysis (difference in mean change, 11.0 \[95% CI, 3.5 to 18.4\]; *P* = .004), but this difference was not significant in the adjusted model, with the baseline KOOS~ADL~ subscore as a covariate (adjusted *P* = .116). There were no between-group differences from baseline to 1 year in the change in any of the other KOOS subscores (*P* \> .05) ([Table 3](#table3-2325967119893920){ref-type="table"}). There were no between-group differences from baseline to 5 years or from baseline to 1 year in the change in the EQ-5D or EuroQol visual analog scale (EQ-VAS) scores (*P* \> .05) ([Table 3](#table3-2325967119893920){ref-type="table"}). There was a difference between groups in the change in the KOOS~SYMPTOMS~ subscore from 3 to 5 years in favor of the nonsurgery group (difference in mean change, 7.9 \[95% CI, 1.8 to 14.1\]; *P* = .011; adjusted *P* = .008) ([Table 3](#table3-2325967119893920){ref-type="table"}).

At the 5-year follow-up, the surgery group scored lower on the KOOS~SYMPTOMS~ compared with the nonsurgery group (mean difference, --8.5 points \[95% CI, --16.4 to --0.7\]; *P* = .034). There were no between-group differences in any of the other KOOS subscores at 5 years ([Table 2](#table2-2325967119893920){ref-type="table"}). At the 1-year follow-up, there were no between-group differences in any of the KOOS subscores ([Table 2](#table2-2325967119893920){ref-type="table"}). There were no between-group differences in EQ-5D or EQ-VAS scores at either the 5- or 1-year follow-up ([Table 2](#table2-2325967119893920){ref-type="table"}).

The 2-way ANCOVA on the change in the KOOS~PAIN~ subscore at 5 years, after controlling for the effect of the KOOS~PAIN~ at baseline, indicated that treatment had a nonsignificant main effect (*P* = .967), mechanical symptoms had a significant main effect (*P* = .026), and the interaction between treatment and mechanical symptoms had a significant effect (*P* = .020) ([Table 4](#table4-2325967119893920){ref-type="table"}). Mechanical symptoms had an effect on the change in the KOOS~PAIN~ subscore at 5 years but only in the surgery group; a significantly larger improvement was observed in patients without compared with those with mechanical symptoms (within-group mean difference, 18.4 \[95% CI, 8.7 to 28.1\]; *P* \< .001) ([Table 5](#table5-2325967119893920){ref-type="table"}). The 2-way ANCOVA on the change in the KOOS~SYMPTOMS~ subscore at 5 years, after controlling for the effect of the KOOS~SYMPTOMS~ at baseline, indicated that treatment had a nonsignificant main effect (*P* = .389), mechanical symptoms had a nonsignificant main effect (*P* = .279), and the interaction between treatment and mechanical symptoms had a significant effect (*P* = .040) (Table 4). Mechanical symptoms had an effect on the change in the KOOS~SYMPTOMS~ subscore at 5 years but only in the surgery group; a significantly larger improvement was observed in patients without compared with those with mechanical symptoms (within-group mean difference, 12.1 \[95% CI, 2.7 to 21.4\]; *P* = .012) ([Table 5](#table5-2325967119893920){ref-type="table"}). The 2-way ANCOVA on the change in the KOOS~ADL~ subscore at 5 years, after controlling for the effect of the KOOS~ADL~ at baseline, indicated that treatment had a nonsignificant main effect (*P* = .451), mechanical symptoms had a nonsignificant main effect (*P* = .100), and the interaction between treatment and mechanical symptoms had a significant effect (*P* = .019) (Table 4). The effect of mechanical symptoms on the change in the KOOS~ADL~ subscore at 5 years was only observed in the surgery group; a significantly larger improvement was observed in patients without compared to patients with mechanical symptoms (within-group mean difference, 14.2 \[95% CI, 5.6 to 22.8\]; *P* = .001) ([Table 5](#table5-2325967119893920){ref-type="table"}).

###### 

Results of 2-Way Analyses of Covariance*^a^*

![](10.1177_2325967119893920-table4)

                                             *df*   *F* Value   *P* Value   Partial η^2^ Value   *R* ^2^ Value
  ------------------------------------------ ------ ----------- ----------- -------------------- ---------------
  Change in KOOS~PAIN~ as DV (n = 99)                                                            0.361
   Treatment group                           1      0.002       .967        0.000                
   Mechanical symptoms                       1      5.100       .026        0.051                
   Treatment group × mechanical symptoms     1      5.634       .020        0.057                
   KOOS~PAIN~ at baseline (covariate)        1      31.713      \<.001      0.252                
  Change in KOOS~SYMPTOMS~ as DV (n = 100)                                                       0.291
   Treatment group                           1      0.749       .389        0.008                
   Mechanical symptoms                       1      1.183       .279        0.012                
   Treatment group × mechanical symptoms     1      4.322       .040        0.044                
   KOOS~SYMPTOMS~ at baseline (covariate)    1      30.708      \<.001      0.244                
  Change in KOOS~ADL~ as DV (n = 98)                                                             0.403
   Treatment group                           1      0.572       .451        0.006                
   Mechanical symptoms                       1      2.761       .100        0.029                
   Treatment group × mechanical symptoms     1      5.706       .019        0.058                
   KOOS~ADL~ at baseline (covariate)         1      38.440      \<.001      0.292                
  Change in KOOS~SPORTS~ as DV (n = 98)                                                          0.154
   Treatment group                           1      0.019       .890        0.000                
   Mechanical symptoms                       1      2.123       .148        0.022                
   Treatment group × mechanical symptoms     1      0.487       .487        0.005                
   KOOS~SPORTS~ at baseline (covariate)      1      11.143      .001        0.107                
  Change in KOOS~QoL~ as DV (n = 99)                                                             0.204
   Treatment group                           1      0.346       .558        0.004                
   Mechanical symptoms                       1      2.003       .160        0.021                
   Treatment group × mechanical symptoms     1      1.817       .181        0.019                
   KOOS~QoL~ at baseline (covariate)         1      15.048      \<.001      0.138                
  Change in EQ-5D as DV (n = 98)                                                                 0.554
   Treatment group                           1      0.455       .502        0.005                
   Mechanical symptoms                       1      0.312       .578        0.003                
   Treatment group × mechanical symptoms     1      0.839       .362        0.009                
   EQ-5D at baseline (covariate)             1      109.670     \<.001      0.541                
  Change in EQ-VAS as DV (n = 95)                                                                0.487
   Treatment group                           1      0.155       .695        0.002                
   Mechanical symptoms                       1      1.310       .255        0.014                
   Treatment group × mechanical symptoms     1      0.489       .486        0.005                
   EQ-VAS at baseline (covariate)            1      81.599      \<.001      0.476                

*^a^*ADL, activities of daily living; DV, dependent variable; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.

###### 

Change in Patient-Reported Outcome Measure Scores From Baseline to 5 Years by Mechanical Symptoms*^a^*

![](10.1177_2325967119893920-table5)

                             Surgery                 Nonsurgery                Between-Group Difference
  -------------------------- ----------------------- ------------------------- --------------------------
  KOOS~PAIN~                                                                   
   No mechanical symptoms                                                      
    n                        20                      15                        
    Mean (95% CI)            36.6 (28.4 to 44.7)     26.9 (17.4 to 36.4)       9.7 (--3.1 to 22.4)
    *P* value                                                                  .136
   Mechanical symptoms                                                         
    n                        45                      19                        
    Mean (95% CI)            18.2 (12.8 to 23.5)     27.5 (19.3 to 35.7)       --9.3 (--19.2 to 0.5)
    *P* value                                                                  .063
   Within-group difference                                                     
    Mean (95% CI)            18.4 (8.7 to 28.1)      --0.6 (--13.0 to 11.9)    
    *P* value                **\<.001**              .925                      
  KOOS~SYMPTOMS~                                                               
   No mechanical symptoms                                                      
    n                        19                      16                        
    Mean (95% CI)            25.1 (17.3 to 33.0)     20.6 (11.7 to 29.4)       4.6 (--7.2 to 16.4)
    *P* value                                                                  .445
   Mechanical symptoms                                                         
    n                        46                      19                        
    Mean (95% CI)            13.1 (8.0 to 18.2)      24.2 (16.4 to 32.1)       --11.1 (--20.5 to --1.8)
    *P* value                                                                  **.020**
   Within-group difference                                                     
    Mean (95% CI)            12.1 (2.7 to 21.4)      --3.6 (--15.6 to 8.3)     
    *P* value                **.012**                .545                      
  KOOS~ADL~                                                                    
   No mechanical symptoms                                                      
    n                        20                      16                        
    Mean (95% CI)            28.3 (21.1 to 35.5)     17.1 (9.0 to 25.2)        11.2 (0.1 to 22.3)
    *P* value                                                                  **.049**
   Mechanical symptoms                                                         
    n                        44                      18                        
    Mean (95% CI)            14.1 (9.4 to 18.8)      19.8 (12.4 to 27.2)       --5.7 (--14.5 to 3.1)
    *P* value                                                                  .199
   Within-group difference                                                     
    Mean (95% CI)            14.2 (5.6 to 22.8)      --2.7 (--13.6 to 8.2)     
    *P* value                **.001**                .622                      
  KOOS~SPORTS~                                                                 
   No mechanical symptoms                                                      
    n                        20                      14                        
    Mean (95% CI)            37.6 (25.5 to 49.8)     32.4 (17.0 to 47.8)       5.2 (--15.1 to 25.5)
    *P* value                                                                  .611
   Mechanical symptoms                                                         
    n                        45                      19                        
    Mean (95% CI)            24.5 (16.5 to 32.5)     27.9 (15.7 to 40.2)       --3.4 (--18.1 to 11.2)
    *P* value                                                                  .641
   Within-group difference                                                     
    Mean (95% CI)            13.1 (--1.3 to 27.6)    4.5 (--15.2 to 24.1)      
    *P* value                .073                    .652                      
  KOOS~QoL~                                                                    
   No mechanical symptoms                                                      
    n                        20                      15                        
    Mean (95% CI)            41.6 (31.1 to 51.1)     31.5 (19.0 to 43.9)       10.2 (--6.5 to 26.8)
    *P* value                                                                  .229
   Mechanical symptoms                                                         
    n                        45                      19                        
    Mean (95% CI)            27.4 (20.5 to 34.3)     31.3 (20.6 to 41.9)       --3.9 (--16.6 to 8.8)
    *P* value                                                                  .547
   Within-group difference                                                     
    Mean (95% CI)            14.2 (1.8 to 26.7)      0.2 (--16.0 to 16.5)      
    *P* value                **.026**                .978                      
  EQ-5D                                                                        
   No mechanical symptoms                                                      
    n                        19                      15                        
    Mean (95% CI)            0.23 (0.15 to 0.31)     0.22 (0.13 to 0.32)       0.01 (--0.12 to 0.14)
    *P* value                                                                  .886
   Mechanical symptoms                                                         
    n                        45                      19                        
    Mean (95% CI)            0.17 (0.12 to 0.23)     0.24 (0.15 to 0.32)       --0.07 (--0.17 to 0.04)
    *P* value                                                                  .201
   Within-group difference                                                     
    Mean (95% CI)            0.06 (--0.04 to 0.16)   --0.02 (--0.14 to 0.11)   
    *P* value                .239                    .819                      
  EQ-VAS                                                                       
   No mechanical symptoms                                                      
    n                        19                      14                        
    Mean (95% CI)            21.2 (15.1 to 27.3)     20.3 (13.2 to 27.4)       0.9 (--8.5 to 10.3)
    *P* value                                                                  .846
   Mechanical symptoms                                                         
    n                        44                      18                        
    Mean (95% CI)            15.6 (11.6 to 19.6)     18.9 (12.6 to 25.3)       --3.3 (--10.8 to 4.2)
    *P* value                                                                  .385
   Within-group difference                                                     
    Mean (95% CI)            5.6 (--1.7 to 12.9)     1.3 (--8.2 to 10.9)       
    *P* value                .133                    .779                      

*^a^*Bolded values indicate statistical significance (*P* \< .05). Adjusted for overall mean scores at baseline. ADL, activities of daily living; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.

At the 5-year follow-up, a moderate to high level of physical activity was reported by a lower proportion of the surgery group compared with the nonsurgery group (41% vs 66%, respectively; *P* = .018). None of the groups showed a significant change in physical activity level from baseline to 5 years (surgery, *P* = .481; nonsurgery, *P* = .057).

Radiographic Findings {#section13-2325967119893920}
---------------------

At the 5-year follow-up, 78% of patients in both the surgery and nonsurgery groups displayed radiographic OA (*P* = .967). Among the 64 patients who had no available radiographs at the 5-year follow-up, 22 patients (10 patients in the surgery group and 12 patients in the nonsurgery group) had grade ≥2 OA, according to the Kellgren-Lawrence grade, at baseline. From baseline to the 5-year follow-up, radiographic deterioration, assessed according to the Kellgren-Lawrence grade, occurred in 60% of the surgery group and 37% of the nonsurgery group. The difference between groups was nonsignificant (*P* = .060).

Response and Dropout Analysis {#section14-2325967119893920}
-----------------------------

Of the 146 patients available for the as-treated analysis, 44 (30%) did not respond to the questionnaire at 5 years, including 19 patients (22%) in the surgery group and 25 (41%) in the nonsurgery group (*P* = .016). Of the 44 nonresponders, 2 had died and 14 had declined further participation. There was no significant difference between responders and nonresponders regarding sex, age, duration of knee pain, knee function, mechanical symptoms, or radiographic OA at baseline (*P* \> .05). The response rate at 5 years was higher among patients with moderate to high levels compared with those with low levels of physical activity at baseline (83% vs 66%, respectively; *P* = .037). There was no significant difference between responders and nonresponders in any of the KOOS subscores, the EQ-5D score, or the EQ-VAS score at baseline (*P* \> .05).

Of the 28 patients eligible for dropout analysis, 24 could be reached, and all agreed to participate in a short telephone interview. Knee surgery was performed in 25% of patients who discontinued study participation and 64% of patients who completed study participation (*P* = .004). These groups were not significantly different in knee pain, knee function, or physical activity level at 5 years (*P* \> .05).

Discussion {#section15-2325967119893920}
==========

The present 5-year follow-up of a randomized study on knee arthroscopic surgery and an exercise program versus only an exercise program in middle-aged patients with meniscal symptoms showed no differences between groups from baseline to 5 years in the changes in the KOOS~PAIN~ subscore or on knee joint radiographs. At the 1-year follow-up, knee arthroscopic surgery provided more benefit compared with no surgery; surgery provided a larger reduction in pain from baseline to 3 months and 1 year.^[@bibr15-2325967119893920]^ This superior improvement in the primary outcome (KOOS~PAIN~) did not persist at the 3-year follow-up in the surgery group^[@bibr14-2325967119893920]^ but persisted in patients who had no mechanical symptoms at baseline.^[@bibr14-2325967119893920]^ The present study showed that, at the 5-year follow-up, even in this subgroup, the positive effect of knee arthroscopic surgery was no longer significant. These results were consistent with a previous systematic review on arthroscopic surgery for the degenerative knee; in that review, they concluded that surgery provided a short-term benefit (up to 6 months) but no benefit after 1 year or longer.^[@bibr52-2325967119893920]^

The potential beneficial effects of knee arthroscopic surgery must be weighed against short-term adverse effects, such as postoperative infections or deep venous thrombosis,^[@bibr52-2325967119893920]^ and long-term negative effects, such as an increased risk of posttraumatic OA.^[@bibr6-2325967119893920],[@bibr13-2325967119893920]^ The present study found no short-term complications, consistent with previous studies in which postoperative complications were rare.^[@bibr5-2325967119893920],[@bibr16-2325967119893920],[@bibr52-2325967119893920]^ However, meniscal tissue resection leads to altered knee joint loading, which increases the contact pressure on the remaining tissues in the joint.^[@bibr4-2325967119893920],[@bibr51-2325967119893920]^ Therefore, meniscectomy might increase the risk of subsequent cartilage injuries.^[@bibr10-2325967119893920],[@bibr37-2325967119893920],[@bibr39-2325967119893920],[@bibr40-2325967119893920]^

The indication for surgery might be a potential confounding factor^[@bibr40-2325967119893920]^ because underlying degenerative joint disease increases the risk of future cartilage degradation. In the present study, radiographic deterioration was not significantly different between the surgery and nonsurgery groups; however, we observed a tendency to detect radiographic deterioration in a larger proportion of patients in the surgery group compared with the nonsurgery group. Nevertheless, an equal proportion in both groups had radiographic OA at the 5-year follow-up. Previous RCTs found a similar result regarding radiographic deterioration between surgery and nonsurgery groups.^[@bibr19-2325967119893920],[@bibr55-2325967119893920]^ In the present study, only 1 patient in each group reported that knee pain worsened by more than 10 points on the KOOS~PAIN~ at 5 years. The low proportions of patients (\<5%) and the equivalent incidence between groups suggested that meniscectomy did not increase the risk of clinical deterioration at 5 years.

For many years, arthroscopic meniscal surgery has been a common procedure^[@bibr9-2325967119893920],[@bibr50-2325967119893920]^; nevertheless, its use in treating degenerative meniscal injuries in middle-aged patients has been challenged.^[@bibr7-2325967119893920],[@bibr8-2325967119893920],[@bibr31-2325967119893920],[@bibr38-2325967119893920]^ Consequently, the rates of arthroscopic meniscal procedures have declined in recent years.^[@bibr34-2325967119893920],[@bibr36-2325967119893920]^ Recently, a clinical guideline for degenerative knee disease and meniscal tears strongly recommended against arthroscopic surgery in nearly all patients with degenerative knee disease.^[@bibr45-2325967119893920]^ Therefore, nonsurgical treatment should be the first-line treatment^[@bibr3-2325967119893920],[@bibr29-2325967119893920]^; indeed, in the present study, prior physical therapy was an inclusion criterion. Exercise therapy and meniscectomy were shown to be equally effective in reducing knee pain and increasing function and performance in patients with degenerative meniscal injuries. In addition, exercise is more effective than surgery for increasing muscle strength.^[@bibr49-2325967119893920]^ The mechanisms underlying the effects of exercise interventions include increased muscle strength, enhanced proprioception, and improved range of motion.^[@bibr43-2325967119893920]^ When the effects of nonsurgical treatment are unsatisfactory, arthroscopic partial meniscectomy can be considered^[@bibr3-2325967119893920],[@bibr29-2325967119893920],[@bibr33-2325967119893920]^ because some subgroups of patients are known to benefit from arthroscopic surgery.^[@bibr21-2325967119893920]^ It remains a challenge in clinical decision making to identify which subgroups of patients with degenerative meniscal injuries are most likely to benefit from knee arthroscopic surgery. Ideally, surgical decision making should be individualized.^[@bibr28-2325967119893920]^ A recent systematic review concluded that long symptom duration, radiological evidence of knee OA, and resection of \>50% of the meniscus were prognostic factors associated with a worse clinical outcome from meniscectomy.^[@bibr11-2325967119893920]^ In the present study, patients with preoperative self-reported mechanical symptoms had worse outcomes from knee arthroscopic surgery than patients without these symptoms. This finding was clinically important because mechanical symptoms have been considered a valid indication for arthroscopic surgery in patients with degenerative knee disease.^[@bibr20-2325967119893920],[@bibr32-2325967119893920]^ Our results were consistent with a recent study that found that, among patients with degenerative knees, mechanical symptoms were associated with a less favorable outcome from knee arthroscopic surgery.^[@bibr46-2325967119893920]^ A plausible interpretation of these findings could be that mechanical symptoms indicate general knee degeneration rather than an isolated meniscal injury.^[@bibr17-2325967119893920],[@bibr46-2325967119893920]^ It should be noted that the present study did not include patients with meniscal root tears that were repaired.

This study has some important strengths, including our evaluations of both PROMs and radiographic findings during the 5-year follow-up. Previous RCTs had only at most 2-year follow-up times,^[@bibr23-2325967119893920],[@bibr26-2325967119893920],[@bibr27-2325967119893920],[@bibr35-2325967119893920],[@bibr47-2325967119893920],[@bibr55-2325967119893920]^ with the exception of 2 studies with a 5-year follow-up.^[@bibr19-2325967119893920]^ When patients are followed for at least 5 years, it is vital to anticipate the possibility that OA might develop. However, most RCTs evaluated only PROMs that focused on pain and function; only 2 previous RCTs have reported radiographic findings.^[@bibr19-2325967119893920],[@bibr55-2325967119893920]^ In addition, the present study has the following strengths: strict inclusion criteria, a single-center study with access to a majority of the population, the characteristics of the health care system within the catchment area were known and described, exercise instructions were administered by physical therapists experienced in knee rehabilitation, and almost all eligible patients agreed to participate in the study.^[@bibr33-2325967119893920]^ Furthermore, at baseline, the allocation sequence was concealed from the orthopaedic surgeon who enrolled and assessed patients. In addition, 1 radiologist, who was blinded to the allocation and treatment, assessed all the radiographs both at baseline and at the 5-year follow-up. Thus, the enrolling orthopaedic surgeon and the radiologist were blinded to the treatment groups.

This study also has several limitations. Therefore, the results should be interpreted with caution. First, the patients were not blinded to the treatment. Moreover, 25% of patients in the nonsurgery group crossed over to undergo surgery, and 11% crossed over in the other direction. The as-treated analysis was used to analyze the effect of the treatment. There were significant differences in KOOS subscores between groups at baseline: the surgery group had more pain and worse function than the nonsurgery group. Presumably, patients with worse symptoms were more likely to undergo surgery. However, although group differences were significant, they were small, and they only reached clinical significance on the KOOS~SPORTS~. Furthermore, only 70% of patients completed the 5-year questionnaire. There were lower response rates in the nonsurgery group that may have affected the results. Nevertheless, the dropout analysis showed that the nonresponders did not differ from participants regarding knee pain, knee function, and physical activity level at 5 years.

In conclusion, knee arthroscopic surgery combined with an exercise program provided no additional long-term benefit after 5 years compared with an exercise program alone in middle-aged patients with meniscal symptoms. Patients without mechanical symptoms experienced better surgical outcomes than those with mechanical symptoms. Radiographic evidence of bone changes showed no difference between treatment groups.
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